NCT00260429View on ClinicalTrials.gov

Collagenase in the Treatment of Dupuytrens Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

August 31, 2005

Study Completion Date

April 30, 2008

Conditions
Dupuytren's Disease
Interventions
BIOLOGICAL

collagenase clostridium histolyticum

Subjects could have received up to three injections of AA4500/placebo into the cord of the affected hand. Each injection was separated by at least 30 days. Individual cords may have received up to a maximum of three injections.

Trial Locations (1)

11794

Stony Brook University Hospital and Mediacl Center, Stony Brook

Sponsors
All Listed Sponsors
collaborator

Biospecifics Technologies Corp.

INDUSTRY

collaborator

Endo Pharmaceuticals

INDUSTRY

lead

Stony Brook University

OTHER